Conduction abnormalities during dipyridamole stress testing.

Area of Science:

• Cardiology
• Clinical Electrophysiology

Background:

• Pharmacological stress testing with dipyridamole is a common diagnostic tool.
• While generally safe, dipyridamole infusions have been associated with adverse cardiac events, including atrioventricular (AV) block.

Purpose of the Study:

• To investigate the incidence and risk factors for AV block during dipyridamole stress testing.
• To identify patient subgroups at increased risk for conduction abnormalities.

Main Methods:

• Retrospective analysis of electrocardiogram (ECG) data from 2010 consecutive patients undergoing dipyridamole stress tests.
• Exclusion of patients with pre-existing second or third-degree AV block.
• Comparison of AV conduction changes between patients with and without baseline conduction abnormalities.

Main Results:

• 17.4% of patients exhibited baseline conduction abnormalities on ECG.
• A transient change in AV conduction or sinus arrest occurred in 0.8% of patients post-dipyridamole infusion.
• Patients with baseline conduction abnormalities had a significantly higher risk (3.14%) of developing AV block compared to those without (0.3%) (P < .0001).

Conclusions:

• Dipyridamole stress testing carries a risk of transient AV block, particularly in patients with pre-existing ECG conduction abnormalities.
• Baseline ECG assessment is critical for stratifying risk before dipyridamole administration.
• Identifying patients with baseline conduction issues can guide preventative strategies and improve safety during pharmacological stress testing.